<DOC>
	<DOCNO>NCT01840449</DOCNO>
	<brief_summary>The aim study identify predictive factor response Lanreotide treatment Acromegaly well Neuroendocrine Tumours .</brief_summary>
	<brief_title>Somatuline Predictive Factors Acromegaly NET</brief_title>
	<detailed_description />
	<mesh_term>Neuroendocrine Tumors</mesh_term>
	<mesh_term>Carcinoid Tumor</mesh_term>
	<mesh_term>Acromegaly</mesh_term>
	<mesh_term>Lanreotide</mesh_term>
	<mesh_term>Angiopeptin</mesh_term>
	<mesh_term>Somatostatin</mesh_term>
	<criteria>Written inform consent ( also mandatory case retrospective documentation subject data ) Diagnosis acromegaly NET intention treat ATG already treatment ATG The subject already include study Participation interventional trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>